However, in advanced cancer, up-regulation of NRF2 helps malignant cells tolerate high levels of ROS and avoid apoptosis by activating metabolic and cell protection genes that help enhance cell proliferation (Kim & Keum, 2016; Menegon, Columbano & Giordano, 2016). The gene discussed is NFE2L2; the disease is cancer.